228 related articles for article (PubMed ID: 35069805)
21. Clinical Characteristics and Short-Term Prognosis of Autoimmune Encephalitis: A Single-Center Cohort Study in Changsha, China.
Deng S; Qiu K; Liu H; Wu X; Lei Q; Lu W
Front Neurol; 2019; 10():539. PubMed ID: 31178819
[No Abstract] [Full Text] [Related]
22. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.
Gadoth A; Pittock SJ; Dubey D; McKeon A; Britton JW; Schmeling JE; Smith A; Kotsenas AL; Watson RE; Lachance DH; Flanagan EP; Lennon VA; Klein CJ
Ann Neurol; 2017 Jul; 82(1):79-92. PubMed ID: 28628235
[TBL] [Abstract][Full Text] [Related]
23. Objective sleep profile in LGI1/CASPR2 autoimmunity.
Devine MF; Feemster JC; Lieske EA; McCarter SJ; Sandness DJ; Steele T; Timm PC; Mandrekar J; Boeve BF; Silber MH; Dubey D; McKeon A; St Louis EK
Sleep; 2022 Feb; 45(2):. PubMed ID: 34953167
[TBL] [Abstract][Full Text] [Related]
24. Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapy.
Mueller C; Elben S; Day GS; Alves P; Hebert J; Tang-Wai DF; Holtmann O; Iorio R; Perani D; Titulaer MJ; Hansen N; Bartsch T; Johnen A; Illes Z; Borm L; Willison AG; Wiendl H; Meuth SG; Kovac S; Bölte J; Melzer N
Clin Neurol Neurosurg; 2023 Jan; 224():107559. PubMed ID: 36549220
[TBL] [Abstract][Full Text] [Related]
25. Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study.
Zhong R; Chen Q; Zhang X; Zhang H; Lin W
Front Immunol; 2022; 13():918396. PubMed ID: 35757705
[TBL] [Abstract][Full Text] [Related]
26. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis].
Li JM; Ma XR; Peng T; Li JH; Lu H
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1947-1951. PubMed ID: 32629594
[No Abstract] [Full Text] [Related]
28. LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.
Nosadini M; Toldo I; Tascini B; Bien CG; Parmeggiani L; De Gaspari P; Zuliani L; Sartori S
J Neuroimmunol; 2019 Oct; 335():577008. PubMed ID: 31352183
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity.
Tan X; Liu Y; Wu X; Guo Y
J Neurol; 2022 Nov; 269(11):5893-5900. PubMed ID: 35781606
[TBL] [Abstract][Full Text] [Related]
30. Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands.
Xue H; Guo X; Jiang Y; Qin L; Wang X; Xu J; Zuo S; Liu Q; Li W
Front Neurol; 2023; 14():1281276. PubMed ID: 38249729
[TBL] [Abstract][Full Text] [Related]
31. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.
Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW
Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China.
Huang T; Liu F; Wang B; Wang C; Hao M; Guo S
Front Immunol; 2023; 14():1213532. PubMed ID: 38152405
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
35. Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis.
Theorell J; Harrison R; Williams R; Raybould MIJ; Zhao M; Fox H; Fower A; Miller G; Wu Z; Browne E; Mgbachi V; Sun B; Mopuri R; Li Y; Waters P; Deane CM; Handel A; Makuch M; Irani SR
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2311049121. PubMed ID: 38319973
[TBL] [Abstract][Full Text] [Related]
36. Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.
Li G; Liu X; Wang M; Yu T; Ren J; Wang Q
Acta Neurol Scand; 2022 Aug; 146(2):137-143. PubMed ID: 35373330
[TBL] [Abstract][Full Text] [Related]
37. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.
Montojo MT; Petit-Pedrol M; Graus F; Dalmau J
Neurologia; 2015 Jun; 30(5):295-301. PubMed ID: 24485651
[TBL] [Abstract][Full Text] [Related]
38. Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.
Qin X; Yang H; Zhu F; Wang Q; Shan W
Front Immunol; 2021; 12():652864. PubMed ID: 34054814
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics of Cognitive Impairment and 1-Year Outcome in Patients With Anti-LGI1 Antibody Encephalitis.
Hang HL; Zhang JH; Chen DW; Lu J; Shi JP
Front Neurol; 2020; 11():852. PubMed ID: 33162923
[No Abstract] [Full Text] [Related]
40. Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China.
Gong X; Chen C; Liu X; Lin J; Li A; Guo K; Zhou D; Hong Z
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33589542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
